Chemical-structure (Chemical Structure)
Topiramate Tablet, Film Coated
Product Images NDC 71335-0325
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1jpg (Figure 1)
The text describes cumulative rates for time to first seizure for two different doses of Topiramate (50mg/day and 400mg/day) over a period of 500 days. A statistical significance is mentioned with a p-value of 0.0002. There is a graph with time in days on the x-axis and cumulative rate on the y-axis.*
Figure-2 (Figure 2)
Label Image (Lbl713350325)
This appears to be a label of Topiramate, a prescription medication manufactured by Sun Pharmaceutical Industries Ltd. The medication is a 100mg tablet that comes in a yellow, round shape, with an imprint "S;711". It is recommended to be stored at room temperature between 20°-25°C (68°-77°F) and kept out of reach of children. The label includes an expiration date of MM/YY and the medication is packaged in a bottle containing 60 tablets with the National Drug Code (NDC) 7133503251 03294601523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
